Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 07, 2019
Bio-Techne announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein production capacity.
read more
Bio-Techne and the Mount Sinai Health System in New York, through Kantaro Biosciences, announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai-developed COVID-19 serology test.
read more
Thursday, August 20, 2020
Bio-Techne, in partnership with Leica Biosystems, announced the automation of RNAscope COVID-19 probes on BOND RX for research use only.
read more
Monday, November 04, 2019
BioAgilytix has acquired Cambridge Biomedical, a CRO based in the Cambridge area of Massachusetts, which also specializes in large molecule bioanalysis.
read more
Monday, February 22, 2016
BioAgilytix, a provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise ...
read more
Thursday, October 07, 2021
BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announced today that it signed a formal, worldwide partnership agreement...
read more
BioAgilytix Labs (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, announced the appointment of Dr. Linda Robbie as Chief Operating Officer.
read more
BioAgilytix Labs, LLC (“BioAgilytix”), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announces the appointment, effective immediately, of Euan Menzies as ...
read more
Thursday, October 14, 2021
BioAgilytix Labs, announced that, following Australian Foreign Investment Review Board ("FIRB") approval, it officially closed the purchase of 360biolabs®. The acquisition of the company, now known as 360biolabs, a BioAgilytix company, expands ...
read more
Wednesday, November 17, 2021
BioAgilytix, a global contract research organization (CRO), announced an agreement to be further capitalized by Cinven, a leading international private investment firm focused on building world-class global companies. Cinven will acquire a majority ...
read more
BioAgilytix Labs, LLC, a global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced that it signed a definitive agreement to purchase 360biolabs®, the ...
read more
Bioanalytical Sciences, dba Inotiv, Inc. has announced that Kenneth Swart, Ph.D., has joined the Company as Vice President, Bioanalytical Sciences.
read more
BioAscent has appointed Dr. Angelo Pugliese as Associate Director of In SilicoDiscovery and Data Analysis to lead the company’s computational chemistry service.
read more
Thursday, September 03, 2020
BioAscent enhanced its service offering with a £1m/$1.3m investment in new instrumentation and equipment.
read more
Bioasis Technologies announced a joint research collaboration with a leading pharmaceutical company.
read more